Concepedia

Jennifer Desrosiers

JD

2

Publications

35

Citations

2

H-Index

2024

Active since

Affiliations

Dana-Farber Brigham Cancer Center(Current)

Harvard University

Dana-Farber Cancer Institute

Jennifer Desrosiers is an author at Dana-Farber Brigham Cancer Center specializing in medicine, pharmacology, and cancer therapeutics.

Top concepts

HealthMedicineOncologyImmunologyPharmacologyBreast CancerImmunotherapyCancer TherapyTumor ImmunityClinical Trials

Publications per year

2024–2025

2

Publications

2

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Ana C. Garrido-Castro, Se Eun Kim, Jennifer Desrosiers et al. · Journal of Clinical Oncology · 2024 · 25 citations

Breast Oncology, Immunology, Pharmacotherapy +21

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Ana C. Garrido-Castro, Noah Graham, Lestat R. Ali et al. · Journal for ImmunoTherapy of Cancer · 2025 · 10 citations · Full text

Rows per page

1–2 of 2